A healthcare provider will consider these factors when recommending the appropriate course of action
GLP-1 Goal Timeline Calculator Estimate time to reach goal weight on Ozempic, Wegovy, Mounjaro, Zepbound, or retatrutide
In most cases, however, back pain during GLP-1-based treatment is manageable and does not necessitate medication discontinuation
Its approval criteria consider both body mass index (BMI) and weight-related comorbidities to ensure suitable candidates benefit from its use (Knop et al., 2023)
Another dangerous side effect linked to semaglutide drugs is a type of blood clot called deep vein thrombosis (DVT)
Examination of absolute standardised mean differences for all the seven trials after weighting showed that all absolute values of standardised mean differences were below 0.1 suggesting good balance between the GLP-1 receptor agonist and the SGLT-2 inhibitor groups (see supplementary figure S3 for trial 1 and supplementary figure S4 for trials 2-7)